Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Dunad Therapeutics, a UK-based developer of protein degradation technology, launched yesterday with £5m ($7m) in funding from venture firm Epidarex Capital. Dunad advances research by co-founder, acting chief executive and chief scientific officer Prof Patrick Gunning, a researcher in University of Toronto Mississauga’s Department of Chemical and Physical Sciences.
Inotec AMD, a UK-based wound healing technology spinout of University of Cambridge, has pocketed £3.4m ($4.7m) in series C funding from Wealth Club. The spinout previously secured $9.1m in February 2020 in a round led by Praetura Ventures with participation from Amadeus Capital Partners, Puhua Capital, Boundary Capital and a group of angel investors.
ArkEdge Space, a Japan-based artificial satellite remote sensing technology developer spun out of University of Tokyo, has raised ¥400m ($3.7m) from venture capital firm Incubate Fund and Real Tech Fund, a vehicle backed by biofuel supplier Euglena, research group Leave a Nest and investment firm SMBC Nikko.
– Additional reporting by Liwen-Edison Fu
